LIP
RANI icon

Lighthouse Investment Partners’s Rani Therapeutics RANI Stock Holding History

Lighthouse Investment Partners’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,840
Closed -$57.8K – 1001
2025
Q4 		$57.8K Buy
+42,840
New +$64.6K ﹤0.01% 847

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Lighthouse Investment Partners's RANI Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Rani Therapeutics (RANI) in Q1 2026, closing a stake of 42,840 shares — an estimated $57.8K sold.

Lighthouse Investment Partners first reported a position in RANI in Q4 2025 and held it in 1 quarter. The position peaked at $57.8K in Q4 2025. 74 funds tracked by Wall St. Rank hold RANI as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Rani Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 42,840 Rani Therapeutics shares in Q1 2026, an estimated $57.8K.
  • Lighthouse Investment Partners first reported a position in Rani Therapeutics in Q4 2025 and held it in 1 quarter.
  • Lighthouse Investment Partners's Rani Therapeutics position peaked at $57.8K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.